- Conditions
- Low-volume Metastasis, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
- Locations
-
- Many locations Multiple Locations, Japan
Clinical trial condition
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Explore clinical trials studying Metastatic Hormone-Sensitive Prostate Cancer (mHSPC). Study availability and eligibility vary by location and protocol.
22 public trials
10 recruiting studies
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) trial results
NCT07140900
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- University of California San Francisco San Francisco, California, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- University of Minnesota Minneapolis, Minnesota, United States
- Cleveland Clinic Foundation Cleveland, Ohio, United States
- Conditions
- Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
- Locations
-
- Univ of Alabama at Birmingham Birmingham, Alabama, United States
- Uni Of Iowa Hospitals And Clinics Iowa City, Iowa, United States
- University of Kansas Cancer Center Westwood, Kansas, United States
- Wichita Urology Group PA Wichita, Kansas, United States
NCT07216248
- Conditions
- Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
- Locations
-
- Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States
NCT07395804
- Conditions
- Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
- Locations
-
- Many Locations, Germany
NCT07241416
- Conditions
- Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
- Locations
-
- The First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital Beijing, Beijing Municipality, China
NCT07181122
- Conditions
- Behavior, Behavioral Symptoms, Depression, +20 more
- Locations
-
- Etlik City Hospital Medical Oncology Department Ankara, Yenimahalle, Turkey (Türkiye)
- Gazi University Medical Oncology Department Ankara, Çankaya, Turkey (Türkiye)
NCT05649943
- Conditions
- Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
- Locations
-
- European Institute of Oncology Milan, Lombardy, Italy
- ASST Santi Paolo e Carlo Milan, Lombardy, Italy
- Istituto Tumori Milano Milan, Mi, Italy
NCT03903835
- Conditions
- Metastatic Castration-resistant Prostate Cancer (mCRPC), Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
- Locations
-
- OLV Ziekenhuis Aalst Aalst, Belgium
- GZA Sint-Augustinus Antwerp, Belgium
- AZ Sint-Jan AV Bruges, Belgium
- AZ Sint-Lucas Bruges, Belgium
Recruiting
Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC
NCT05956639
- Conditions
- Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
- Locations
-
- Urology dpt, First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China